Abstract

Induced pluripotent stem cells (IPSCs) for cardiac applications

Philip Wong En Hou, Director, R&D Unit (RDU), National Heart Centre

IPSCs have now been used for a slue of clinical applications including cell therapy, toxicity testing and drug screening. We described some of the ongoing research of our group on IPSCs for cardiac applications in clinical syndromes such as arhythmogenic right ventricular dysplasia and prolonged QT syndrome.